Search

In Stock

Buy Tymlos (abaloparatide) Online

DISEASE INDICATIONS: Osteoporosis

MANUFACTURER: Radius Health, Inc.

USAGE: Subcutaneous

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Tymlos is a prescription medication used to treat osteoporosis, a condition characterized by the weakening of bones, which can lead to an increased risk of fractures and bone fractures. It is specifically indicated for postmenopausal women at high risk of fracture or those who have failed other osteoporosis treatments.

$2,636.72

Clear
Compare

Tymlos is a prescription medication used to treat osteoporosis, a condition characterized by the weakening of bones, which can lead to an increased risk of fractures and bone fractures. It is specifically indicated for postmenopausal women at high risk of fracture or those who have failed other osteoporosis treatments.

Here is a detailed description of Tymlos:

Active Ingredient:

  • Abaloparatide: Abaloparatide is a synthetic peptide that mimics the action of parathyroid hormone-related protein (PTHrP) and is classified as a parathyroid hormone-related peptide analog. It stimulates bone formation and increases bone density, helping to strengthen bones and reduce the risk of fractures.

Dosage Forms:

Tymlos is typically available in the form of a subcutaneous injection (an injection given just below the skin) that is self-administered by the patient.

Indications:

Tymlos is indicated for the treatment of osteoporosis in postmenopausal women at high risk for fracture, which includes those with a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have not responded well to other osteoporosis medications.

Usage:

The dosing and administration of Tymlos are typically determined by a healthcare provider. It is usually administered as a daily subcutaneous injection. Patients are instructed on how to self-administer the medication and are advised to follow their healthcare provider’s instructions carefully.

Benefits:

Tymlos helps strengthen bones and increase bone density, reducing the risk of fractures in postmenopausal women with osteoporosis. It can improve bone health and overall quality of life by reducing the likelihood of fractures.

Precautions:

Before starting Tymlos, patients should consult with a healthcare provider. It is important to inform the healthcare provider of any allergies, medical conditions, or other medications being taken, as these factors can affect the safety and efficacy of the medication. Patients should also have their calcium and vitamin D levels optimized while taking Tymlos.

Side Effects:

Common side effects of Tymlos may include dizziness, headache, nausea, and joint pain. In some cases, patients may experience injection site reactions, such as redness or pain at the injection site. Patients should discuss any side effects or concerns with their healthcare provider.

Duration of Treatment:

The duration of Tymlos treatment should be determined by a healthcare provider based on the individual patient’s needs. It is generally recommended for use in postmenopausal women at high risk of fracture, and treatment decisions should be made in consultation with a healthcare provider.

In conclusion, Tymlos (abaloparatide) is a medication used to treat osteoporosis in postmenopausal women at high risk of fracture. It helps strengthen bones and increase bone density, reducing the risk of fractures. Patients should use it as directed by their healthcare provider and be aware of potential side effects and precautions associated with its use.

Package

30 doses of 80 mcg (2000 mcg/mL)

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Stelara (ustekinumab) Injection Online

From $5,034.51
(0 Reviews)
Stelara, known by its generic name Ustekinumab, is a prescription medication used in the treatment of certain autoimmune diseases, primarily plaque psoriasis, psoriatic arthritis, and Crohn's disease.

Buy Skyrizi (Risankizumab) Online

From $14,517.47
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: AbbVie Ltd USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Therapeutic Goods Administration (TGA) Skyrizi (risankizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the interleukin-23 (IL-23) pathway, which is involved in the development and progression of psoriasis.

Buy Tremfya (guselkumab) Online

$2,860.64
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Janssen Biotech USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA) Tremfya is a pharmaceutical medication that contains the active ingredient guselkumab. It belongs to a class of medications known as interleukin-23 (IL-23) inhibitors and is primarily used in the treatment of certain chronic skin conditions, particularly moderate to severe plaque psoriasis. Guselkumab works by targeting specific proteins in the immune system that play a role in the development of psoriatic skin lesions, thereby reducing the symptoms associated with this condition.

Buy Rinvoq (upadacitinib) Online

$1,955.31
(0 Reviews)
Rinvoq is a pharmaceutical medication that contains the active ingredient upadacitinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used to treat autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Upadacitinib works by targeting specific enzymes in the immune system, helping to reduce inflammation and alleviate the symptoms associated with these conditions.

Buy Taltz (ixekizumab) Online

From $2,499.58
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Taltz (ixekizumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is a monoclonal antibody that works by blocking interleukin 17A (IL-17A), a cytokine that plays a key role in the development and progression of these inflammatory diseases.

Buy Olumiant (baricitinib) Online

From $1,070.33
(0 Reviews)
DISEASE INDICATIONS: Rheumatoid Arthritis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Olumiant (baricitinib) is a prescription medication used to treat rheumatoid arthritis (RA), alopecia areata, and COVID-19. It is a Janus kinase (JAK) inhibitor, which means that it blocks the activity of JAK enzymes. JAK enzymes are involved in the signaling pathway that leads to inflammation.

Buy Tymlos (abaloparatide) Online

$2,636.72
(0 Reviews)
DISEASE INDICATIONS: Osteoporosis MANUFACTURER: Radius Health, Inc. USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Tymlos is a prescription medication used to treat osteoporosis, a condition characterized by the weakening of bones, which can lead to an increased risk of fractures and bone fractures. It is specifically indicated for postmenopausal women at high risk of fracture or those who have failed other osteoporosis treatments.

Back to Top
Product has been added to your cart